COVID Antibody Products May Get To Use Viral Load As Surrogate For Mutant-Targeted Versions

 
• By Sue Sutter
Footrace
Monoclonal antibody developers and regulators are trying to keep up with changes in the coronavirus that causes COVID-19. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards